alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

112TH CONGRESS 

1ST SESSION H. R. 2892 

To amend the Internal Revenue Code of 1986 to suspend the capital gains 

tax for 10 years for taxpayers other than corporations. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 12, 2011 

Mr. FINCHER introduced the following bill; which was referred to the 

Committee on Ways and Means 

A BILL 

To amend the Internal Revenue Code of 1986 to suspend 

the capital gains tax for 10 years for taxpayers other 

than corporations. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Invest in America Act 

5 of 2011’’. 

6 SEC. 2. TEMPORARY EXCLUSION OF NET CAPITAL GAIN OF 

7 TAXPAYERS OTHER THAN CORPORATIONS. 

8 (a) IN GENERAL.—Part I of subchapter P of chapter 

9 1 of the Internal Revenue Code of 1986 (relating to treatVerDate Mar 15 2010 05:57 Sep 14, 2011 Jkt 099200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H2892.IH H2892

rfrederick on DSK6VPTVN1PROD with BILLS
2 

•HR 2892 IH

1 ment of capital gains) is amended by adding at the end 

2 the following new section: 

3 ‘‘SEC. 1203. TEMPORARY EXCLUSION OF NET CAPITAL GAIN 

4 OF TAXPAYERS OTHER THAN CORPORA5 TIONS. 

6 ‘‘(a) IN GENERAL.—In the case of a taxpayer other 

7 than a corporation, gross income shall not include an 

8 amount equal to the net capital gain of the taxpayer for 

9 the taxable year. 

10 ‘‘(b) DIVIDENDS TREATED AS NET CAPITAL GAIN.— 

11 For purposes of this section, the term ‘net capital gain’ 

12 means net capital gain (determined without regard to this 

13 subsection) increased by qualified dividend income (as de14 fined in section 1(h)(11)). 

15 ‘‘(c) APPLICATION OF SECTION.—This section shall 

16 apply to taxable years beginning after December 31, 2011, 

17 and before January 1, 2022.’’. 

18 (b) CONFORMING AMENDMENTS.— 

19 (1) Subsection (h) of section 1 of such Code is 

20 amended by adding at the end the following new 

21 paragraph: 

22 ‘‘(12) APPLICATION OF SUBSECTION SUS23 PENDED DURING EXCLUSION OF NET CAPITAL

24 GAIN.—This subsection shall not apply to taxable 


rfrederick on DSK6VPTVN1PROD with BILLS
3 

•HR 2892 IH

1 years beginning after December 31, 2011, and be2 fore January 1, 2022.’’. 

3 (2) Paragraph (3) of section 55(b) of such Code 

4 is amended by adding at the end the following flush 

5 sentence: 

6 ‘‘This paragraph shall not apply to taxable years be7 ginning after December 31, 2011, and before Janu8 ary 1, 2022.’’. 

9 (3) Section 1222 of such Code is amended by 

10 adding at the end the following new sentence: 

11 ‘‘Determinations under this section shall be made before 

12 the application of section 1203.’’. 

13 (4) The table of sections for part I of sub14 chapter P of chapter 1 of such Code is amended by 

15 adding at the end the following new item: 

‘‘Sec. 1203. Exclusion of net capital gain of taxpayers other than corporations.’’. 

16 (c) EFFECTIVE DATE.—The amendments made by 

17 this section shall apply to taxable years beginning after 

18 December 31, 2011. 

Æ 


rfrederick on DSK6VPTVN1PROD with BILLS
---

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
  18 U.S.C. SECTION 1350, 
  AS ADOPTED PURSUANT TO
  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of UltraGuard Water
  Systems Corp.. (the "Company") on Form 10-QSB for the period ended March 31,
  2005 as filed with the Securities and Exchange Commission on the date hereof
  (the "Report"), I, Kenneth Fielding, the President and Chief Executive Officer
  of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant
  to section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

|(1) | the Report fully complies with the requirements of
        section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                                      
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                                    
|(2) | the information contained in the Report fairly presents,
        in all material respects, the financial condition and result of operations
        of the Company.

|Date: May 18, 2005 |                                      
|------------------ | -------------------------------------
|                   |                                      
|                   | /s/ Ken Fielding                     
|                   | Ken Fielding                         
|                   | President and Chief Executive Officer

---
**EXHIBIT
      14**





**PLM
      Financial Services Inc.**


**Code
      Of Ethics**





The
      Board
      of Directors, Executive Officers and Employees of PLM Financial Services Inc.,
      (the Company") the Trustee of the Trust, operate under a Code of Ethics that
      acknowledges and supports the integrity and values of the Company.





The
      Code
      of Ethics ensures all issues are handled honestly and openly, including
      notification to the appropriate person or persons associated with the Company
      of
      any material transaction(s) or relationship(s) that could be expected to become
      a conflict and that any conflicts of interest between personal and professional
      relationships are handled expediently and fairly. All Employees are provided
      with a clearly defined process to follow for any issues they feel are
      questionable or relate to possible wrongdoing without any fear of repercussion
      from Management.





PLM
      Financial Services Inc. conducts its business within the framework of all
      applicable governmental laws, rules and regulations.





The
      Code
      of Ethics is subject to periodic review by the Board of Directors to assure
      they
      continue to meet any modifications required by changes in regulations, the
      activities of the Company or to support the interests of the
      shareholders.































































35
EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Amendment No. 1 to Quarterly Report of Braintech, Inc. (the Company) on Form 10-QSB for the three months ended March 31,
2007 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Frederick Weidinger, the Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to
section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and
result of operations of the Company.



|                           
|---------------------------
|/s/ Frederick Weidinger    
|Frederick Weidinger        
|Principal Executive Officer
|March 18, 2008
Exhibit 32.1

               CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS
              ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
                                   ACT OF 2002

In connection with the quarterly report of Cell Tech International Incorporated
(the "Company") on Form 10-Q for the period ended June 30, 2004 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Marta C. Carpenter, Chief Executive Officer and Chief Accounting Officer of the
Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss. 906
of the Sarbanes-Oxley Act of 2002, that:

      1.    The Report fully complies with the requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

      2.    The information contained in the Report fairly presents, in all
            material respects, the financial condition and results of operations
            of the Company.


                                                     /s/ Marta C. Carpenter
                                                     ---------------------------
                                                     Marta C. Carpenter
                                                     Chief Executive Officer and
                                                     Chief Accounting Officer

                                                     DATED: August 23, 2004
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Charles & Colvard, Ltd. (the Company) on Form 10-Q for the period ending June 30, 2007 as filed with the Securities and Exchange Commission on the date hereof (the
Report), I, James R. Braun, Vice President of Finance and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                                                      |  | 
|----------------------------------------------------- |  | 
|/s/ James R. Braun                                    |  | 
|James R. Braun                                        |  | 
|Vice President of Finance and Chief Financial Officer |  | 
|August 6, 2007                                        |  |
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3004 Introduced in House (IH)]

112th CONGRESS
  1st Session
                                H. R. 3004

 To designate the facility of the United States Postal Service located 
  at 260 California Drive in Yountville, California, as the ``Private 
         First Class Alejandro R. Ruiz Post Office Building''.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 21, 2011

  Mr. Thompson of California introduced the following bill; which was 
      referred to the Committee on Oversight and Government Reform

_______________________________________________________________________

                                 A BILL

 
 To designate the facility of the United States Postal Service located 
  at 260 California Drive in Yountville, California, as the ``Private 
         First Class Alejandro R. Ruiz Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PRIVATE FIRST CLASS ALEJANDRO R. RUIZ POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 260 California Drive in Yountville, California, shall be 
known and designated as the ``Private First Class Alejandro R. Ruiz 
Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Private 
First Class Alejandro R. Ruiz Post Office Building''.
                                 <all>
```
[Federal Register Volume 82, Number 185 (Tuesday, September 26, 2017)]
[Notices]
[Page 44877]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20580]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Research Advisory Committee on Gulf War Veterans' Illnesses; 
Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under the 
Federal Advisory Committee Act that the Research Advisory Committee on 
Gulf War Veterans' Illnesses will meet on October 30, 2017, in Room 230 
at 810 Vermont Avenue NW., Washington, DC, from 8:00 a.m. until 3:30 
p.m. (Eastern). All sessions will be open to the public, and for 
interested parties who cannot attend in person, there is a toll-free 
telephone number (800) 767-1750; access code 56978#.
    The purpose of the Committee is to provide advice and make 
recommendations to the Secretary of Veterans Affairs on proposed 
research studies, research plans, and research strategies relating to 
the health consequences of military service in the Southwest Asia 
theater of operations during the Gulf War in 1990-1991.
    The Committee will review VA program activities related to Gulf War 
Veterans' illnesses, and updates on relevant scientific research 
published since the last Committee meeting. Presentations will include 
updates on the VA Gulf War research program, descriptions of new areas 
of research in gastrointestinal disorders, and phenotyping research 
that can be applied to the health problems of Gulf War Veterans. Also, 
there will be a discussion of Committee business and activities.
    The meeting will include time reserved for public comments in the 
afternoon. A sign-up sheet for 5-minute comments will be available at 
the meeting. Individuals who wish to address the Committee may submit a 
1-2 page summary of their comments for inclusion in the official 
meeting record. Members of the public may also submit written 
statements for the Committee's review to Dr. Victor Kalasinsky via 
email at <a href="/cdn-cgi/l/email-protection#14627d77607b663a7f757875677d7a677f6d5462753a737b62"><span class="__cf_email__" data-cfemail="780e111b0c170a56131914190b11160b1301380e19561f170e">[email protected]</span></a>.
    Because the meeting is being held in a government building, a photo 
I.D. must be presented as part of the clearance process. Therefore, any 
person attending should allow an additional 15 minutes before the 
meeting begins. Any member of the public seeking additional information 
should contact Dr. Kalasinsky, Designated Federal Officer, at (202) 
443-5600.

    Dated: September 21, 2017.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2017-20580 Filed 9-25-17; 8:45 am]
BILLING CODE 8320-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 10.24
 FORM OF
CHANGE OF CONTROL AGREEMENT
 Agreement Effective Date Company Employee
 RECITALS
     1.
    
    Definitions.
 Awards
 Base Salary
 Cause




---



##### 



CCC
 Change of Control
 Exchange Act
  Transaction
  Change of Control Termination
 COBRA
 Code
 2




---



##### 



Company Equity Plans
 Release Exhibit
A
 Resignation for Good Reason
      Severance Payment [24/12]
 Severance Period
 Change of Control Termination
 Payment upon Change of Control Termination
 3




---



##### 



Employee Release
 Other Benefits
 Excise Tax Cutback
  4




---



##### 



Payments
  Accounting Firm
 Threshold Amount Excise Tax
 Dispute Resolution Procedures
 5




---



##### 



At-Will Employment
 General Provisions
 Governing Law
 Successors and Assigns
 No Waiver of Breach
 Severability
 Entire Agreement; Amendment
 Modification; Waivers
 6




---



##### 



Duplicate Counterparts
 Interpretation
 No Mitigation
 Withholding of Taxes
 Drafting Ambiguities; Representation by Counsel
 7




---



##### 



AVANIR PharmaceuticalsBy:Employee(Signature)(Print Name)
 8




---



##### 



EXHIBIT
A
 GENERAL RELEASE
 Release Effective Date Company Employee
 RECITALS
 Agreement
  AGREEMENT
 Release Agents Related Entities ADEA
 Section 1542 Waiver




---



##### 



Waiver of Certain Claims
 No Undue Influence
 Governing Law
 Severability
 Counterparts
 Dispute Resolution Proceedings CCC




---



##### 



Entire Agreement
 Modification; Waivers
 Amendment
 Dated:Employee Name
```

[Federal Register Volume 82, Number 185 (Tuesday, September 26, 2017)]
[Notices]
[Page 44842]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20479]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]

Bulk Manufacturer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration as bulk 
manufacturers of various classes of controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as manufacturers of various basic classes of controlled 
substances. Information on previously published notices is listed in 
the table below. No comments or objections were submitted for these 
notices.

------------------------------------------------------------------------
           Company                  FR docket             Published
------------------------------------------------------------------------
Insys Manufacturing, LLC....  82 FR 23066           May 19, 2017.
Eli-Elsohly Laboratories....  82 FR 23067           May 19, 2017.
Patheon Pharmaceuticals,      82 FR 23067           May 19, 2017.
 Inc..
National Center for Natural   82 FR 23068           May 19, 2017.
 Products.
Research NIDA MPROJECT
Chemtos LLC.................  82 FR 23068           May 19, 2017.
Chemtos LLC.................  82 FR 25335           June 1, 2017.
Johnson Matthey               82 FR 23069           May 19, 2017.
 Pharmaceutical.
Materials, Inc..............
American Radiolabeled         82 FR 23070           May 19, 2017.
 Chemicals.
------------------------------------------------------------------------

    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823(a) and determined that the registration of 
these registrants to manufacture the applicable basic classes of 
controlled substances is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated each of the 
company's maintenance of effective controls against diversion by 
inspecting and testing each company's physical security systems, 
verifying each company's compliance with state and local laws, and 
reviewing each company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer 
to the above listed persons.

    Dated: September 20, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-20479 Filed 9-25-17; 8:45 am]
 BILLING CODE 4410-09-P
```
#### Heidi K. Erickson vs. David A. Somers & another.1

April 21, 2006.

*Supreme Judicial Court,*

Superintendence of inferior courts. *Practice, Civil,*Appeal, Bond. *Summary Process,*Appeal.

*Heidi K. Erickson,*pro se.

*Norma B. Somers,*pro se.

1

Norma B. Somers.

The petitioner, Heidi K. Erickson, appeals from a judgment of a single justice of this court denying her petition under G. L. c. 211, § 3, and from the denial of her subsequent motion for a stay or other injunctive relief. We affirm.

The petition sought relief from a decision of a judge of the Superior Court declining to waive an appeal bond in connection with an appeal from a summary process judgment in the District Court, pursuant to G. L. c. 239, § 5. As we said in *Matter of an Appeal Bond (No. 1),*428 Mass. 1013 (1998):

> “The single justice of this court correctly denied the c. 211, § 3, petition because the petitioner had an adequate alternative remedy. The proper course for her to have followed, if she wished further to challenge the bond, was to refuse to pay the bond, suffer the dismissal of her summary process appeal, and then appeal to the Appeals Court (on the limited bond issue) from the order of dismissal.”

*Id.,*citing *Ford*v. *Braman,*30 Mass. App. Ct. 968, 970 (1991). See *Tamber*v. *Desrochers,*45 Mass. App. Ct. 234 (1998); *Home Sav. Bank*v. *Camillo,*45 Mass. App. Ct. 910 (1998).

We express no view on the merits of the petitioner’s claims concerning either the appeal bond or the summary process judgment.2

*Judgment affirmed.*

2

On the record before him the single justice did not err or otherwise abuse his discretion in denying Erickson’s request for a stay or other injunctive relief.
I 

112TH CONGRESS 

1ST SESSION H. R. 2712 

To ensure that all of Brevard County, Florida, is treated as a HUBZone, 

and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 30, 2011 

Mrs. ADAMS introduced the following bill; which was referred to the 

Committee on Small Business 

A BILL 

To ensure that all of Brevard County, Florida, is treated 

as a HUBZone, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Shuttle Workforce Re5 vitalization Act of 2011’’. 

6 SEC. 2. BREVARD COUNTY, FLORIDA. 

7 (a) IN GENERAL.—During the covered period, any 

8 portion of Brevard County, Florida, that is not otherwise 

9 a HUBZone, as such term is defined under section 3(p) 


rfrederick on DSKD9S0YB1PROD with BILLS
2 

•HR 2712 IH

1 of the Small Business Act (15 U.S.C. 632(p)), shall be 

2 treated as a HUBZone for purposes of that Act. 

3 (b) COVERED PERIOD DEFINED.—In this section, the 

4 term ‘‘covered period’’ means the period beginning on the 

5 date of enactment of this Act and ending on January 1, 

6 2020. 

Æ 


rfrederick on DSKD9S0YB1PROD with BILLS